Related by context. All words. (Click for frequent words.) 69 paroxysmal AF 68 sinus rhythm 68 acute myocardial infarction AMI 66 deep venous thromboses 66 NSTEMI 66 reinfarction 66 myocardial infarctions 66 NYHA Class II 66 β blockers 65 atrioventricular block 65 beta blocker therapy 65 stable angina 65 systolic dysfunction 65 elevated triglyceride levels 65 coronary revascularization 65 patients undergoing CABG 65 prolonged QT interval 65 preserved ejection fraction 65 MACCE 65 macroalbuminuria 65 perioperative mortality 65 postoperative atrial fibrillation 64 CYPHER Stent 64 ARCOXIA 64 unstable angina pectoris 64 antiarrhythmic drug 64 ischemic cardiomyopathy 64 left ventricular dysfunction 64 postoperative complication 64 hemodialysis patients 64 tachyarrhythmias 64 thrombocytopenic 64 Hypotension 64 atrial fibrillation AF 64 paroxysmal atrial fibrillation 64 TEAEs 64 symptomatic VTE 64 ACTEMRA TM 64 revascularization procedures 64 Erythropoietic therapies may 64 upper gastrointestinal bleeding 64 VT VF 64 undergoing coronary artery 64 systolic hypertension 64 hypokalemia 64 OAB symptoms 63 Infusion Reactions Severe 63 HIV HCV coinfected 63 ADHF 63 Stent thrombosis 63 multivessel disease 63 underwent resection 63 recurrent VTE 63 candidemia 63 antithrombotic therapies 63 carotid stenosis 63 paclitaxel eluting stents 63 tachyarrhythmia 63 underwent CABG 63 thromboembolic complications 63 cerebrovascular events 63 liver transplant recipients 63 arterial thromboembolic events 63 intravenous RSD# 63 Postoperative complications 63 XIENCE V PROMUS Stent 63 Thal Dex 63 cardiac resynchronization 63 reperfusion therapy 63 reoperations 63 PICSO ® 63 definite stent thrombosis 63 non valvular atrial 63 antiarrhythmic drugs 63 ventricular tachyarrhythmia 63 autonomic dysfunction 63 morphometric vertebral fractures 63 revascularizations 63 postoperative AF 62 colorectal adenoma 62 asymptomatic PAD 62 thromboses 62 PRADAXA #mg 62 ximelagatran 62 TMP SMX 62 cerebral infarctions 62 infarction NSTEMI 62 patients undergoing percutaneous 62 onset diabetes mellitus 62 EXJADE 62 ICD shocks 62 postoperative complications 62 Wisconsin Sleep Cohort 62 decompensated heart failure 62 hypoglycaemic episodes 62 nondiabetic patients 62 NYHA functional class 62 silent ischemia 62 pacemaker implantation 62 aldosterone antagonists 62 myocardial infarction MI 62 MADIT CRT trial 62 severe exacerbations 62 NATRECOR ® 62 VIIBRYD 62 HBeAg negative 62 symptomatic intracranial 62 atherothrombotic events 62 LVSD 62 lipid lowering agents 62 coronary artery bypass grafts 62 cerebral vasospasm 62 lipid lowering therapy 62 atherothrombotic disease 62 T1DM 62 valvular disease 62 thromboembolism 62 atrial arrhythmias 62 UA NSTEMI 62 venous thromboembolic disease 61 acromegalic patients 61 nonischemic cardiomyopathy 61 nadolol 61 Atrial fibrillation AF 61 Arrhythmias 61 atrial fibrillation 61 T2DM 61 cardiogenic shock 61 riociguat 61 PEGINTRON TM 61 noncardiac 61 diastolic heart 61 rhythm disturbances 61 anti arrhythmic drug 61 thromboembolic events 61 unstable angina UA 61 receiving XGEVA 61 venous thromboembolisms 61 recurrent glioblastoma multiforme 61 recurrent ischemia 61 intravitreal injections 61 subclinical hypothyroidism 61 elevated troponin 61 acute aortic dissection 61 cardiovascular hospitalizations 61 nonvertebral fractures 61 invasive candidiasis 61 relapsed MM 61 PSVT 61 percutaneous coronary interventions 61 intravenous diuretics 61 salmeterol fluticasone 61 PSA nadir 61 receiving VELCADE 61 FluCAM arm 61 repeat revascularization 61 Venous thromboembolism 61 induce orthostatic hypotension 61 oral anticoagulation 61 NYHA Class 61 nonfatal MI 61 PLX STROKE targeting 61 cardioembolic stroke 61 advanced adenomas 61 hyperphenylalaninemia HPA due 61 CIMZIA ™ 61 alemtuzumab treated 61 hypoxemia 61 dopaminergic therapy 61 cTnT 61 ruptured aneurysms 61 electrical cardioversion 61 PRADAXA 61 intravesical therapy 61 elevated ALT 61 recurrent venous thromboembolism 61 infective endocarditis 61 paroxysmal 61 undergone radical prostatectomy 61 NATRECOR R 61 symptomatic BPH 61 infarctions 61 prostate cancer CaP 61 TAXUS p value 61 LV dysfunction 61 caspofungin 61 coinfected patients 61 rebleeding 61 oral antidiabetic medication 61 proliferative retinopathy 61 prodromal symptoms 61 tirofiban 61 TAXUS Express Stent 61 neurologic complications 61 COPD exacerbation 61 pCR 61 angina pectoris 61 mild renal insufficiency 60 ß blockers 60 acute decompensation 60 anastomotic leak 60 CTEPH 60 NNT = 60 ertapenem 60 malignant neoplasm 60 thromboembolic 60 NSTE ACS 60 dysglycemia 60 oxycodone CR 60 myelodysplastic myeloproliferative diseases 60 hypertension diabetes mellitus 60 CABG coronary artery 60 syncopal 60 certolizumab 60 mcg kg REBETOL 60 ventricular tachycardia VT 60 ALT flares 60 SORT OUT III 60 recurrent DVT 60 landmark ATHENA trial 60 ejection fractions 60 nonvertebral fracture 60 PSADT 60 urolithiasis 60 ventricular arrhythmia 60 MIRAPEX 60 invasive aspergillosis 60 hepatectomy 60 symptomatic atrial fibrillation 60 immune thrombocytopenic purpura ITP 60 HSCT 60 ARIXTRA 60 endophthalmitis 60 HeFH 60 Acute myocardial infarction 60 CABG surgeries 60 ipsilateral stroke 60 haemorrhagic stroke 60 achieved ACR# 60 VADT 60 revascularization procedure 60 cerebral angiography 60 proliferative diabetic retinopathy 60 artery stenosis 60 Cypher Stent 60 atherosclerotic renal artery stenosis 60 NYHA Class III 60 CVD mortality 60 hyperkalemia 60 Operative mortality 60 bypass grafting 60 liver transplantations 60 ischemic complications 60 antiplatelet medication 60 XIENCE V demonstrated 60 adjunctive placebo 60 coronary revascularization procedures 60 stent thromboses 60 glycated hemoglobin levels 60 liver metastasis 60 rFVIIa 60 serum creatinine levels 60 symptomatic paroxysmal AF 60 generalized edema 60 HCV RESPOND 2 60 drug eluting stent implantation 60 Aortic stenosis 60 Lamictal XR 60 hemorrhagic strokes 60 poor metabolizers 60 laboratory abnormalities 60 postoperative morbidity 60 antiplatelet drugs 60 Serious adverse reactions 60 CsA 60 haloperidol Haldol 60 SJIA 60 subtrochanteric 60 resynchronization therapy 60 leukemia AML 60 vertebral fracture 60 rosuvastatin #mg 60 intracranial hemorrhage ICH 60 hypophosphatemia 60 advanced adenoma 60 perioperative complications 60 lipid lowering medications 60 cardiac dysfunction 60 ICD implants 60 postoperative mortality 60 somatostatin analog 60 underwent coronary angiography 60 severe mitral regurgitation 60 ventricular tachyarrhythmias 60 stratifying patients 60 hepatorenal syndrome 60 REYATAZ r arm 60 VaD 60 aspirin clopidogrel 60 asymptomatic carotid stenosis 60 hemorrhagic complications 59 levetiracetam 59 hyperglycaemia 59 nonobstructive CAD 59 CIMZIA TM certolizumab pegol 59 malignant neoplasms 59 evaluable subjects 59 nadroparin 59 biochemical relapse 59 chest radiographs 59 recurrent myocardial infarction 59 primary hypercholesterolemia 59 retrospective cohort 59 variceal bleeding 59 BYSTOLIC 59 sustained ventricular tachycardia 59 intravenous bisphosphonates 59 intracerebral hemorrhages 59 MGd 59 venlafaxine Effexor 59 thrombolytic therapy 59 opioid dependent 59 clinically evaluable patients 59 NMIBC 59 myocardial infarction 59 Atypical Hemolytic Uremic Syndrome 59 venous blood clots 59 RSD# oral 59 deep vein thromboses 59 glucocorticoid therapy 59 nonfatal myocardial infarction MI 59 cardiovascular hospitalization 59 echocardiographic parameters 59 periprocedural 59 gastrointestinal perforation 59 lopinavir r arm 59 unstable angina 59 mL/min/#.# m 2 59 AGILECT R 59 PREZISTA r arm 59 NYHA class 59 heavily pretreated 59 anticoagulant warfarin 59 endometrial carcinoma 59 oral FTY# 59 acute myocardial infarctions 59 osteoporotic vertebral fractures 59 recanalization 59 onset seizures 59 cinacalcet 59 bypass graft CABG surgery 59 nontraumatic 59 superficial vein thrombosis 59 Anticoagulants 59 DAPT 59 irregular quivering 59 anticoagulants blood thinners 59 severe hypoglycaemia 59 TAVR 59 corticosteroid therapy 59 eplerenone 59 microalbuminuria 59 HBeAg negative patients 59 recurrent acute pancreatitis 59 EDSS scores 59 paroxysmal supraventricular tachycardia 59 receiving VICTRELIS 59 anterior uveitis 59 aneurysmal subarachnoid hemorrhage 59 Hypertensive 59 postintervention 59 tipranavir r 59 tenecteplase 59 leiomyomas 59 placebo dexamethasone 59 postoperative pulmonary 59 acute coronary syndromes ACS 59 MULTAQ 59 AA Amyloidosis 59 skeletal metastases 59 CRVO 59 GnRH agonists 59 coronary blockages 59 retinal vein occlusion 59 dermatologic reactions 59 experienced virologic failure 59 torsade de pointes 59 angioplasties stents 59 GH deficiency 59 sotalol 59 prednisone prednisolone 59 Brinavess 59 adrenalectomy 59 left ventricular hypertrophy 59 isolated systolic hypertension 59 Afib 59 onset AF 59 Subgroup analysis 59 partial onset seizures 59 atherothrombosis 59 fluticasone salmeterol 59 chlamydial infection 59 aortic insufficiency 59 myocardial infarctions MIs 59 neuropsychiatric symptoms 59 milrinone 59 serum phosphorous 59 perioperatively 59 atypical ductal hyperplasia 59 ST elevation myocardial 59 diabetes mellitus DM 59 AGILECT ® 59 CIN3 59 QTc prolongation 59 Coronary Artery Bypass Graft 59 bradycardia 59 asystole 59 homozygous familial hypercholesterolemia 59 progressive dyspnea 59 thrombotic events 59 antithrombotic therapy 59 allogeneic HSCT 59 aminotransferases 59 pancreatic resection 59 symptomatic aortic stenosis 59 cerebral infarction 59 alanine aminotransferase ALT 59 nondiabetic 59 cilostazol 59 pancytopenia 59 symptomatic hyponatremia 59 coronary insufficiency 59 hypercholesterolaemia 59 infarcts 59 coronary intervention 59 lung resection 59 intracerebral hemorrhage 59 APTIVUS r 59 receiving prophylactic anticoagulation 59 headache nasopharyngitis 59 binary restenosis 59 colectomy 59 progressive PsA 59 juvenile idiopathic arthritis 59 aldosterone antagonist 59 chorioamnionitis 59 ICDs implanted 59 microbleeds 59 T2 lesions 59 lenalidomide dexamethasone 59 PASI scores 59 Chronic Heart Failure 59 amisulpride 59 Exacerbations 59 uncontrolled hypertension 59 nicardipine 59 SCr 59 nonadherence 59 recurrent atrial fibrillation 59 total thyroidectomy 59 colorectal adenomas 59 de novo AML 59 infarction STEMI 59 transaminase elevations 59 elevated serum creatinine 59 severe hypoglycemic 59 aged ≥ 59 primary percutaneous coronary 59 biventricular pacing 59 colorectal liver metastases 58 acute coronary syndromes 58 QT intervals 58 ATACAND 58 angiotensin converting enzyme inhibitors 58 MADIT II 58 MGUS 58 neutropenic patients 58 hematologic toxicity 58 AGHD 58 acute STEMI 58 HCV SPRINT 58 QTcF 58 interstitial pneumonia 58 revascularisation 58 hyperacute 58 euthymic patients 58 torsades de pointes 58 LVEF 58 elevated LDL cholesterol 58 obscure gastrointestinal bleeding 58 nonalcoholic steatohepatitis NASH 58 benazepril 58 thyrotoxicosis 58 Complication rates 58 virological response 58 radical retropubic prostatectomy 58 HBeAg positive 58 Asymptomatic 58 Arch Intern Med 58 clot busting therapy 58 cerebrovascular accidents 58 mcg albinterferon alfa 2b 58 perioperative morbidity 58 HBeAg seroconversion 58 lymphocytosis 58 pericardial effusion 58 arteriovenous access 58 ventricular fibrillation VF 58 DMARD therapy 58 hemoglobin A1c levels 58 events MACE 58 thromboprophylaxis 58 parkinsonian symptoms 58 bullous 58 primary generalized tonic 58 Acute Coronary Syndromes ACS 58 intravenous cyclophosphamide 58 coronary stenosis 58 persistent pulmonary hypertension 58 SGPT 58 status epilepticus 58 superficial bladder cancer 58 myocardial ischemia 58 symptomatic carotid stenosis 58 coronary revascularizations 58 achieved CCyR 58 CHD CVD 58 elective PCI 58 nonfasting triglyceride levels 58 abnormal glucose tolerance 58 olmesartan 58 reflux esophagitis 58 hepatitis C genotype 58 defibrillator CRT D 58 angioplasty stenting 58 TAXUS Stent 58 Prehypertension 58 myocardial fibrosis 58 chronic eosinophilic leukemia 58 noncardiac surgery 58 chronic periodontitis 58 moderate renal impairment 58 null responder 58 generalized tonic clonic seizures 58 acute myocardial infarction MI 58 KRAS mutations occur 58 intracerebral haemorrhage 58 locoregional recurrence 58 IFN beta 58 kidney transplant recipients 58 acute PAO 58 postsurgical 58 antihypertensive therapy 58 grade cervical intraepithelial 58 stable angina pectoris 58 anticlotting drugs 58 nonmetastatic prostate cancer 58 intracranial atherosclerosis 58 carotid revascularization 58 Non Alcoholic Steatohepatitis 58 biliary tract cancer 58 mixed hyperlipidemia 58 malperfusion 58 thrombotic complications 58 dyslipidaemia 58 Chlamydia trachomatis infection 58 intracranial stenosis 58 stage IIIb IV 58 macrovascular events 58 placebo controlled studies 58 overt nephropathy 58 left ventricular systolic 58 renal tumors 58 extrapyramidal symptoms 58 systemic corticosteroid 58 hemodynamically significant 58 postoperative chemotherapy 58 tegaserod 58 recurrent GBM 58 COPD exacerbations 58 elevated IOP 58 eosinophilic asthma 58 carotid artery stenting 58 acute myocardial infarction 58 cardiac resynchronisation therapy 58 IOP lowering 58 crossclamp 58 resuscitated cardiac arrest 58 CP CPPS 58 pulmonary artery banding 58 severe asthma exacerbations 58 failure ADHF 58 chronic thromboembolic pulmonary 58 radioiodine therapy 58 Hydroxyurea 58 cryptogenic stroke 58 adalimumab Humira 58 Ejection Fraction 58 Pulmonary embolism 58 Torsades de Pointes 58 total abdominal hysterectomy 58 renal dysfunction 58 risperidone Risperdal 58 Atypical antipsychotics 58 psoriatic arthritis PsA 58 coronary artery occlusion 58 Events MACE 58 undergoing CABG 58 OSAHS 58 partial remissions 58 hsCRP levels 58 Neovascular AMD 58 debilitating complication 58 carotid atherosclerosis 58 intracerebral hemorrhage ICH 58 severe neutropenia 58 unfavorable cytogenetics 58 Dronedarone 58 OPCAB 58 VTE prophylaxis 58 conjunctival hyperemia 58 concomitant antibiotics 58 calcineurin inhibitor 58 MCyR 58 fluvastatin 58 pheochromocytoma 58 osteoporotic vertebral compression fractures 58 diastolic dysfunction 58 pulmonary dysfunction 58 reinterventions 58 angiographic outcomes 58 warfarin therapy 58 empyema 58 clopidogrel Plavix 58 Recurrences 58 curative resection 58 urinary symptoms 58 intracranial hypertension 58 EDARBI 58 interferon ribavirin 58 carotid endarterectomy CEA 58 chronic renal insufficiency 58 CLA supplementation 58 lupus nephritis 58 PAOD 58 undergoing radical prostatectomy 58 venous thromboembolic events 58 severe periodontitis 58 coronary stent implantation 58 antiepileptic drugs AEDs 58 nonsevere 58 concomitant AEDs 58 nondiabetics 58 myocardial infarction ventricular fibrillation 58 acid suppressive medications 58 lipid abnormalities 58 diarrhea nausea fatigue 58 cytopenias 58 fragility fracture 58 octreotide LAR 58 inotropes 58 elevated LDH 58 Impaired glucose tolerance 58 hypogonadal men 58 leucopenia 58 IPAH 58 dose Iluvien 58 sirolimus stent 58 untreated OSA 58 timepoints 58 osteosarcomas 58 Ventricular Tachycardia 58 microvascular complications 58 CYT# potent vascular disrupting 58 ischemic strokes 58 nonfasting triglycerides 58 dyslipidemia hypertension diabetes 58 TKAs 58 pyelonephritis 58 CI #.#-#.# [001] 58 cardiac tamponade 57 recurrent glioblastoma 57 receiving golimumab 57 PCIs 57 arrhythmias 57 allogeneic transplants 57 HF hospitalization 57 lacunar 57 â ‰ ¥ 57 metachronous 57 LAGB 57 % CI #.#-#.# [003] 57 enalapril 57 varices 57 salpingo oophorectomy 57 prostate TURP 57 lower extremity amputations 57 biologic DMARD 57 mcg QD 57 Zavesca R 57 TMC# r 57 LQTS 57 nonischemic 57 paricalcitol 57 thrombus aspiration 57 Benign prostatic hyperplasia BPH 57 atrial tachyarrhythmias 57 severe renal impairment 57 carotid artery blockage 57 nulliparous women 57 airflow obstruction 57 renal insufficiency 57 fibrinolysis 57 MetS 57 tapentadol ER 57 chronic HBV 57 EDSS score 57 adverse cytogenetics 57 tolterodine ER 57 lipid lowering drugs 57 generalized seizures 57 nonalcoholic steatohepatitis 57 plasminogen activators 57 occlusive disease 57 venous thrombosis 57 phase IIb study 57 radial artery grafts 57 gout flares 57 adjuvant tamoxifen 57 oral Hycamtin 57 Eisenmenger syndrome 57 virologic failure 57 serum phosphate levels 57 juvenile idiopathic arthritis JIA 57 gallbladder disease 57 ibandronate 57 hepatic metastases 57 Radical prostatectomy 57 Cimzia TM 57 esophageal perforation 57 habitual snorers 57 arterial calcification 57 Heavy menstrual bleeding 57 Excessive daytime sleepiness 57 advanced neoplasia 57 abnormal lipid 57 acute humoral rejection 57 NYHA 57 psychiatric comorbidities 57 noncardiovascular mortality 57 fibrinolytic therapy 57 segment elevation myocardial 57 stroke hypertension palpitations 57 tolvaptan 57 stenoses 57 Acute Decompensated Heart Failure 57 androgen suppression therapy 57 intestinal metaplasia 57 ventricular tachycardia 57 oesophageal adenocarcinoma 57 hypoglycemic events 57 Infarct 57 arteriography 57 neurologic sequelae 57 transaminase levels 57 pericardial effusions 57 hypoperfusion 57 INVEGA ® 57 Carotid Revascularization Endarterectomy vs. 57 TURBT 57 alanine aminotransferase 57 EEG abnormalities 57 ruboxistaurin 57 bezafibrate 57 CK MB 57 liver resection 57 symptomatic AF 57 antiretroviral naive 57 cardiovascular mortality 57 metastatic malignant 57 troponin T 57 Renal dysfunction 57 DVT PE 57 Acute Myocardial Infarction 57 anticoagulation therapy 57 macrovascular disease 57 MMSE scores 57 BENICAR HCT 57 occlusion CRVO 57 acid regurgitation 57 diabetic ketoacidosis DKA 57 uncoated stents 57 hypercalcemia 57 HCV infections 57 myocardial infarction stroke 57 chronic hemodialysis 57 genital herpes infections 57 EFFEXOR XR 57 immunocompetent 57 frequent awakenings 57 Febrile neutropenia 57 CIMZIA TM 57 Thrombolysis 57 QRS duration 57 metastatic malignant melanoma 57 Postoperative 57 metoprolol tartrate 57 acutely decompensated congestive heart 57 TNF antagonist 57 renal cell carcinomas 57 white matter hyperintensities 57 chronic GVHD 57 VFEND 57 CC genotype 57 smoldering myeloma 57 antiarrhythmic medications 57 doxorubicin docetaxel 57 femoral shaft fractures 57 mcg BID 57 del 5q MDS 57 CRT Ds 57 desvenlafaxine succinate 57 cardiomyopathies 57 reintervention 57 venous thromboembolism 57 underwent surgical resection 57 Avandia Actos 57 invasive ductal 57 episodic migraine 57 histologically confirmed 57 giant cell arteritis 57 microvascular disease 57 inguinal hernia repair 57 teriflunomide 57 SLNB 57 C1 INH deficiency 57 aortic atherosclerosis 57 URTI 57 diastolic blood pressures 57 de novo lesions 57 ischemic lesions 57 amoxicillin clavulanate 57 RYGB 57 hyperlipemia 57 primary patency 57 carotid plaques 57 pulmonary metastases 57 detrusor overactivity 57 hypertension congestive heart 57 cardiomegaly 57 complete cytogenetic response 57 hepatic resection 57 FRAGMIN 57 corrected QT interval 57 plasma creatinine 57 CCyR 57 Prostatitis 57 ADPKD 57 proctitis 57 Overactive Bladder OAB 57 DES implantation 57 neurologic symptoms 57 K ras mutations 57 rosuvastatin Crestor 57 protease inhibitor PI 57 atypical antipsychotic drugs 57 psychiatric morbidity 57 GISTs 57 calcified plaques 57 aortic valve stenosis 57 genital HSV 57 ribavirin therapy 57 preterm deliveries 57 neurological manifestations 57 Catheter ablation 57 oral corticosteroid 57 confidence interval #.#-#.# 57 refractory ischemia 57 serum phosphate 57 serum calcium levels 57 dosing cohort 57 amenorrhoea 57 oral anticoagulants 57 adenomatous polyps 57 ischemic stroke 57 bone marrow reticulin deposition 57 preserved LVEF 57 ST Segment Elevation 57 relapsing remitting MS RRMS 57 gouty arthritis 57 systemic hypotension 57 pyrexia mucositis sepsis febrile 57 thrombocytopenic patients 57 afib 57 visceral metastases 57 NHANES III 57 undergoing bariatric surgery 57 subclinical hyperthyroidism 57 CrCl 57 lymphoproliferative disorder 57 cirrhotic patients 57 subgroup analyzes 57 squamous histology 57 coronary angiograms 57 Nesiritide 57 vaginal hysterectomy 57 femoral neck fracture 57 typical antipsychotics 57 achieved sustained virological 57 ticlopidine 57 thyrotropin levels 57 Unstable Angina 57 myopathy rhabdomyolysis 57 euthyroid 57 squamous cell lung cancer 57 alteplase 57 PONV 57 HBeAg positive patients 57 mcg doses 57 TAXUS stent 57 receiving INTRON 57 imipenem 57 hypertension hypercholesterolemia 57 QTc 57 epithelial tumors 57 endoscopic remission 57 #mg/day [001] 57 corticosteroid dose 57 COPAXONE R 57 decompensation 57 chemoembolization 57 cranial irradiation 57 Left ventricular hypertrophy 57 undetectable HBV DNA 57 Am J Cardiol 57 ICD implantation 57 Acute Coronary Syndromes 57 atherogenic dyslipidemia 57 renal impairment 57 artery bypass 57 chronic hepatitis cirrhosis 57 androgen deprivation 57 8mg/kg 57 immunomodulatory therapy 57 syncope fainting 57 triiodothyronine 57 sertraline Zoloft 57 mitral valve replacement 56 CIN2 + 56 colorectal cancer incidence 56 paroxetine Paxil 56 renal allograft 56 Angioedema 56 severe aortic stenosis 56 atrophic gastritis 56 Cognitive impairment 56 NPH insulin 56 microangiopathy 56 thyroid nodules 56 syndromal 56 intra abdominal abscess 56 transrectal ultrasound guided 56 systemic embolism 56 newer atypical antipsychotics 56 postoperative infections 56 Exacerbation 56 zolmitriptan 56 overt hypothyroidism 56 HGPIN 56 STEMIs 56 infliximab Remicade 56 vasodilators 56 osteoporotic compression fractures 56 cytogenetic responses 56 transfusion syndrome 56 hyperhomocysteinemia 56 mechanically ventilated patients 56 ALT elevations 56 dosing cohorts 56 serum urate 56 lumbar spinal stenosis LSS 56 seropositive patients 56 AML MDS 56 primary aldosteronism 56 hyperoxaluria 56 rhythm abnormalities 56 headache abdominal pain 56 serum uric acid 56 HIV uninfected 56 complete remissions 56 SRBD 56 aspartate aminotransferase AST 56 systemic corticosteroids 56 Renal impairment 56 non metastatic osteosarcoma 56 NEUPOGEN 56 mycophenolate mofetil 56 concomitant medications 56 hypoglycemic episodes